64 related articles for article (PubMed ID: 23250620)
1. Comparison of chemotherapeutic efficacy between LCNEC diagnosed using large specimens and possible LCNEC diagnosed using small biopsy specimens.
Tokito T; Kenmotsu H; Watanabe R; Ito I; Shukuya T; Ono A; Nakamura Y; Tsuya A; Naito T; Murakami H; Takahashi T; Ohde Y; Kondo H; Endo M; Kameya T; Nakajima T; Mori K; Yamamoto N
Int J Clin Oncol; 2014 Feb; 19(1):63-7. PubMed ID: 23250620
[TBL] [Abstract][Full Text] [Related]
2. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
[TBL] [Abstract][Full Text] [Related]
3. A Semiquantitative Scoring System May Allow Biopsy Diagnosis of Pulmonary Large Cell Neuroendocrine Carcinoma.
Baine MK; Sinard JH; Cai G; Homer RJ
Am J Clin Pathol; 2020 Jan; 153(2):165-174. PubMed ID: 31593583
[TBL] [Abstract][Full Text] [Related]
4. Outcomes for Surgery in Large Cell Lung Neuroendocrine Cancer.
Raman V; Jawitz OK; Yang CJ; Voigt SL; Tong BC; D'Amico TA; Harpole DH
J Thorac Oncol; 2019 Dec; 14(12):2143-2151. PubMed ID: 31557535
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
Popov P; Steindl A; Wolff L; Bergen ES; Eckert F; Frischer JM; Widhalm G; Fuereder T; Raderer M; Berghoff AS; Preusser M; Kiesewetter B
Clin Exp Metastasis; 2024 Feb; 41(1):25-32. PubMed ID: 38064128
[TBL] [Abstract][Full Text] [Related]
6. Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma.
Kasahara N; Wakuda K; Omori S; Nakashima K; Ono A; Taira T; Kenmotsu H; Naito T; Murakami H; Mori K; Watanabe R; Endo M; Nakajima T; Yamada M; Takahashi T
Mol Clin Oncol; 2017 May; 6(5):718-722. PubMed ID: 28529747
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Patients with Large-Cell Neuroendocrine Carcinoma of the Lung.
Çırak AK; Ceylan KC; Varol Y; Karadeniz G; Aydoğdu Z; Acar A; Balcı G; Kömürcüoğlu B; Mertoğlu A; Öndeş Z; Tekgül S; Vayısoğlu G; Yalnız E
Turk Thorac J; 2020 May; 21(3):150-155. PubMed ID: 32584230
[TBL] [Abstract][Full Text] [Related]
8. New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts.
Lantuejoul S; Fernandez-Cuesta L; Damiola F; Girard N; McLeer A
Transl Lung Cancer Res; 2020 Oct; 9(5):2233-2244. PubMed ID: 33209646
[TBL] [Abstract][Full Text] [Related]
9. Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Derks JL; Leblay N; Thunnissen E; van Suylen RJ; den Bakker M; Groen HJM; Smit EF; Damhuis R; van den Broek EC; Charbrier A; Foll M; McKay JD; Fernandez-Cuesta L; Speel EM; Dingemans AC;
Clin Cancer Res; 2018 Jan; 24(1):33-42. PubMed ID: 29066508
[No Abstract] [Full Text] [Related]
10. Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.
Christopoulos P; Engel-Riedel W; Grohé C; Kropf-Sanchen C; von Pawel J; Gütz S; Kollmeier J; Eberhardt W; Ukena D; Baum V; Nimmrich I; Sieder C; Schnabel PA; Serke M; Thomas M
Ann Oncol; 2017 Aug; 28(8):1898-1902. PubMed ID: 28535181
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Iida Y; Wakuda K; Kenmotsu H; Doshita K; Kodama H; Nishioka N; Miyawaki E; Miyawaki T; Mamesaya N; Kobayashi H; Omori S; Ko R; Ono A; Naito T; Murakami H; Sugino T; Gon Y; Takahashi T
Sci Rep; 2024 Apr; 14(1):7641. PubMed ID: 38561461
[TBL] [Abstract][Full Text] [Related]
12. The prognosis analysis of organ metastatic patterns in lung large cell neuroendocrine carcinoma: A population-based study.
Chen K; Dai P; Ni J; Xiang Y; Gu L
Front Oncol; 2022; 12():1050800. PubMed ID: 36568210
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L; Fan Y; Lu H
Pathol Oncol Res; 2022; 28():1610730. PubMed ID: 36304941
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Dissection of Treatment Patterns and Outcome for Patients With Metastatic Large-Cell Neuroendocrine Lung Carcinoma.
Fisch D; Bozorgmehr F; Kazdal D; Kuon J; Klotz LV; Shah R; Eichhorn F; Kriegsmann M; Schneider MA; Muley T; Stenzinger A; Bischoff H; Christopoulos P
Front Oncol; 2021; 11():673901. PubMed ID: 34307143
[TBL] [Abstract][Full Text] [Related]
16. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities.
Ferrara MG; Stefani A; Simbolo M; Pilotto S; Martini M; Lococo F; Vita E; Chiappetta M; Cancellieri A; D'Argento E; Trisolini R; Rindi G; Scarpa A; Margaritora S; Milella M; Tortora G; Bria E
Front Oncol; 2021; 11():650293. PubMed ID: 33937057
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV Stage.
Lowczak A; Kolasinska-Cwikla A; Osowiecka K; Glinka L; Palucki J; Rzepko R; Doboszynska A; Cwikla JB
Medicina (Kaunas); 2021 Jan; 57(2):. PubMed ID: 33525370
[No Abstract] [Full Text] [Related]
18. Outcomes of Patients with Clinical Stage I-IIIA Large-Cell Neuroendocrine Lung Cancer Treated with Resection.
Lowczak A; Kolasinska-Cwikla A; Ćwikła JB; Osowiecka K; Palucki J; Rzepko R; Glinka L; Doboszyńska A
J Clin Med; 2020 May; 9(5):. PubMed ID: 32392725
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of cisplatin-etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC.
Prelaj A; Rebuzzi SE; Del Bene G; Giròn Berrìos JR; Emiliani A; De Filippis L; Prete AA; Pecorari S; Manna G; Ferrara C; Rossini D; Longo F
ERJ Open Res; 2017 Jan; 3(1):. PubMed ID: 28382303
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
